Open book policy « Charlie Teo Foundation

When it comes to our books, we’re an open book

At the Charlie Teo Foundation we’re not only changing the game when it comes to research, but also when it comes to financial transparency. Yes, we’re an open book.

Why are we stating this?

Here in Australia there are no mandatory standards or rules defining how charities report on their costs. This means charities classify costs in different ways, and are rarely transparent to donors about how this is done. This makes it almost impossible to properly compare one charity to another. Many charities classify certain costs as program expenses not as admin costs if they feel they are directly attributable to the activities of the charity.

We’ve decided to do things differently

At the Charlie Teo Foundation what you see is what you get. Our numbers may not look as good as other charities but that’s primarily because we don’t do any cost allocations that could make our numbers look more favourable.

Our Commitment to You

1. Publish easy-to-understand graphs on our website.

2. Update these after the end of each financial quarter.

3. Report on how we’re spending our total income. We’ll also report on our charity reserves. These are funds saved before being committed and spent in pursuit of our purpose - to beat brain cancer.

4. Be clear. So just know that whenever we talk about our “costs”, we are talking about both our fundraising costs and admin costs.

5. Publish our audited reports for each financial year.

Let’s breakdown our spending even further

News

Engineering the Next Oncolytic Viral Therapy for DIPG

A/Prof Marta Alonso and her research team at the University of Navarra, Spain.

Australian Superstar of STEM making strides in the fight against childhood brain cancer

Dr Jessica Buck and her research team at The Kids Research Institute Australia, Perth.

Imaging Technologies Revolutionise our Understanding of Brain Tumour Microenvironment

Prof. Johanna Joyce and her team at the University of Lausanne, Switzerland.

Pioneering blood test for non-invasive detection of Paediatric Brain Cancer

Craig Horbinski, M.D., PhD, director of Neuropathology at Northwestern Medicine, USA.

Breakthrough in GBM therapy using new hydrogel and FLASH radiotherapy

A/Prof. David Cormode and A/Prof Jay Dorsey at the University of Pennsylvania, USA.

National Press Club Address for Medical Research Week

Our funded researcher today gave the National Press Club address...